Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5′ untranslated region.

Publication date: Jan 08, 2025

One of the hallmarks of RNA viruses is highly structured untranslated regions (UTRs) which are often essential for viral replication, transcription, or translation. In this report, we discovered a series of coumarin derivatives that bind to a four-way RNA helix called SL5 in the 5′ UTR of the SARS-CoV-2 RNA genome. To locate the binding site, we developed a sequencing-based method namely cgSHAPE-seq, in which an acylating probe was directed to crosslink with the 2′-OH group of ribose at the binding site to create read-through mutations during reverse transcription. cgSHAPE-seq unambiguously determined a bulged G in SL5 as the primary binding site, which was validated through mutagenesis and in vitro binding experiments. The coumarin derivatives were further used as a warhead in designing RNA-degrading chimeras to reduce viral RNA expression levels. The optimized RNA-degrading chimera C64 inhibited live virus replication in lung epithelial carcinoma cells.

Open Access PDF

Concepts Keywords
Carcinoma Binding
Degrading Cgshape
Genome Chimeras
Live Coumarin
Viral Cov
Degrading
Derivatives
Replication
Rna
Sars
Seq
Sequencing
Transcription
Untranslated
Viral

Semantics

Type Source Name
disease IDO site
pathway KEGG Viral replication
pathway REACTOME Translation
disease IDO replication
disease MESH carcinoma
drug DRUGBANK Coumarin
disease IDO host
pathway KEGG Ribosome
disease IDO protein
disease IDO cell
disease MESH point mutations
drug DRUGBANK Mechlorethamine
drug DRUGBANK Pearl (hyriopsis cumingii)
drug DRUGBANK Coenzyme M
disease IDO assay
disease MESH dissociation
drug DRUGBANK Piperazine
drug DRUGBANK Gold
drug DRUGBANK Imidazole
disease IDO process
drug DRUGBANK Dimethyl sulfoxide
disease MESH mutation rate
drug DRUGBANK Polyethylene glycol
drug DRUGBANK Fluorescein
disease MESH virus infection
disease MESH infection
drug DRUGBANK Sodium ascorbate
drug DRUGBANK Silicon dioxide
drug DRUGBANK Sodium bicarbonate
drug DRUGBANK Water
drug DRUGBANK Nitrogen
disease IDO reagent
pathway REACTOME Digestion
drug DRUGBANK Potassium Chloride
drug DRUGBANK Tromethamine
drug DRUGBANK Phencyclidine
drug DRUGBANK ATP
drug DRUGBANK Urea
disease IDO colony
drug DRUGBANK Cefaclor
drug DRUGBANK Phosphate ion
drug DRUGBANK Methylcellulose
drug DRUGBANK Gentian violet cation
disease MESH virus titer
disease MESH hypoxia
disease MESH cancer
disease IDO infectivity
disease MESH COVID 19
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Copper
pathway REACTOME Reproduction

Original Article

(Visited 3 times, 1 visits today)